BACKGROUND: A history of a preeclamptic pregnancy has been associated with subsequent increased risk of cardiovascular disease in the mother and decreased risk of breast cancer in both the mother and offspring. The concentrations of steroid sex hormones, angiogenic factors, and other proteins during pregnancy are important components of the in utero environment and may mediate the association of preeclampsia with later health outcomes. This study sought to compare an extensive profile of biological markers in both maternal and umbilical cord samples in preeclamptic and uncomplicated pregnancies of a predominantly African-American population. METHODS: Steroid sex hormones, angiogenic factors, and components of the insulin-like growth factor axis were measured in maternal and umbilical cord sera from 48 pregnancies complicated by preeclampsia and 43 uncomplicated pregnancies. Regression models estimated the associations of these markers with preeclampsia, after adjusting for maternal and gestational age. RESULTS: Concentrations of androgens (testosterone p = 0.06 and androstenedione p = 0.08) and the anti-angiogenic factors soluble fms-like kinase 1 (p = 0.004) and soluble endoglin (p = 0.004) were higher in the maternal circulation of women diagnosed with preeclampsia. These findings also were noted when the analyses were restricted to only African-American participants (77% of overall study population). Furthermore, among African-Americans, cord insulin-like growth factor-1 was lower in preeclamptic pregnancies than in controls. CONCLUSIONS: The associations of maternal androgens and anti-angiogenic factors with preeclampsia are consistent with prior reports from predominantly Caucasian populations. Alterations in these analytes as well as other maternal and fetal biomarkers in preeclampsia could mediate the associations of preeclampsia with later health consequences.
BACKGROUND: A history of a preeclamptic pregnancy has been associated with subsequent increased risk of cardiovascular disease in the mother and decreased risk of breast cancer in both the mother and offspring. The concentrations of steroid sex hormones, angiogenic factors, and other proteins during pregnancy are important components of the in utero environment and may mediate the association of preeclampsia with later health outcomes. This study sought to compare an extensive profile of biological markers in both maternal and umbilical cord samples in preeclamptic and uncomplicated pregnancies of a predominantly African-American population. METHODS:Steroid sex hormones, angiogenic factors, and components of the insulin-like growth factor axis were measured in maternal and umbilical cord sera from 48 pregnancies complicated by preeclampsia and 43 uncomplicated pregnancies. Regression models estimated the associations of these markers with preeclampsia, after adjusting for maternal and gestational age. RESULTS: Concentrations of androgens (testosterone p = 0.06 and androstenedione p = 0.08) and the anti-angiogenic factors soluble fms-like kinase 1 (p = 0.004) and soluble endoglin (p = 0.004) were higher in the maternal circulation of women diagnosed with preeclampsia. These findings also were noted when the analyses were restricted to only African-American participants (77% of overall study population). Furthermore, among African-Americans, cord insulin-like growth factor-1 was lower in preeclamptic pregnancies than in controls. CONCLUSIONS: The associations of maternal androgens and anti-angiogenic factors with preeclampsia are consistent with prior reports from predominantly Caucasian populations. Alterations in these analytes as well as other maternal and fetal biomarkers in preeclampsia could mediate the associations of preeclampsia with later health consequences.
Authors: Ravi Thadhani; Walter P Mutter; Myles Wolf; Richard J Levine; Robert N Taylor; Vikas P Sukhatme; Jeffrey Ecker; S Ananth Karumanchi Journal: J Clin Endocrinol Metab Date: 2004-02 Impact factor: 5.958
Authors: Richard J Levine; Cong Qian; Sharon E Maynard; Kai F Yu; Franklin H Epstein; S Ananth Karumanchi Journal: Am J Obstet Gynecol Date: 2006-04 Impact factor: 8.661
Authors: Alan Leviton; Olaf Dammann; Elizabeth N Allred; Robert M Joseph; Raina N Fichorova; T Michael O'Shea; Karl C K Kuban Journal: Int J Dev Neurosci Date: 2018-02-02 Impact factor: 2.457
Authors: Juan Yang; Michelle Pearl; Gerald N DeLorenze; Roberto Romero; Zhong Dong; Laura Jelliffe-Pawlowski; Robert Currier; Monica Flessel; Martin Kharrazi Journal: Am J Obstet Gynecol Date: 2016-04-09 Impact factor: 8.661
Authors: Mark J Powell; Suzanne M Dufault; Jill E Henry; Anna C Allison; Renata Cora; Christopher C Benz Journal: J Oncol Date: 2019-08-14 Impact factor: 4.375
Authors: Erin P Ferranti; Jennifer K Frediani; Rebecca Mitchell; Jolyn Fernandes; Shuzhao Li; Dean P Jones; Elizabeth Corwin; Anne L Dunlop Journal: J Pregnancy Date: 2020-02-19